TC
XGN icon

Truvestments Capital’s Exagen XGN Stock Holding History

Truvestments Capital’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$26.3K Sell
5,659
-510
-8% -$1.92K ﹤0.01% 648
2026
Q1 		$18.5K Hold
6,169
– – ﹤0.01% 657
2025
Q4 		$37.5K Buy
6,169
+3,225
+110% +$29.4K 0.01% 493
2025
Q3 		$32.4K Buy
2,944
+473
+19% +$4.19K 0.01% 508
2025
Q2 		$17.2K Buy
+2,471
New +$15K ﹤0.01% 558

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
Silvercrest Asset Management
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
Kennedy Capital Management
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

Truvestments Capital's XGN Position: Q2 2026 in Review

Truvestments Capital reduced its Exagen (XGN) stake by 8.3% in Q2 2026, selling an estimated $1.92K and leaving 5,659 shares worth $26.3K. The position accounts for ﹤0.01% of the portfolio, ranked #648.

Truvestments Capital first reported a position in XGN in Q2 2025 and has held it in 5 quarters since. The position peaked at $37.5K in Q4 2025. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • Truvestments Capital held 5,659 shares of Exagen worth $26.3K as of Q2 2026.
  • Truvestments Capital sold 510 Exagen shares in Q2 2026, an estimated $1.92K.
  • Exagen made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #648 holding.
  • Truvestments Capital first reported a position in Exagen in Q2 2025 and has held it in 5 quarters since.
  • Truvestments Capital's Exagen position peaked at $37.5K in Q4 2025.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.